Pfizer and J&J end development of Alzheimer's drug
Monday, August 6, 2012 - 17:00
in Health & Medicine
NEW YORK (AP) -- Pfizer Inc. and Johnson & Johnson say they are ending development of a once-promising drug designed to treat Alzheimer's disease after the treatment failed in two late-stage clinical trials....